1 Aug 2026Open access
Targeting CDK‐2 With Novel Indole‐Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico StudiesPublisher siteDrug Development Research, Cancer-related Molecular Pathways
UniversitiesZainab M. Elsayed
Active, last published 2026
In synthesis and biological activity
Zainab M.
Elsayed
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Kafrelsheikh University
Claim Your Profile17
H-index
867
Citations
Zainab has not officially claimed their profile. If you are Zainab, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ainab M. Elsayed is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Zainab's work has been cited 867 times across 7 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×19Enzyme function and inhibition×11Cancer therapeutics and mechanisms×9Synthesis and Catalytic Reactions×8Click Chemistry and Applications×5
04 · Where I am
Affiliations
Affiliation on published researchKafrelsheikh UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
43 works23 Jul 2026Open access
In silico pipeline for GSK 3β inhibitor discovery in Alzheimer’s disease using pharmacophore screening, docking, ADME filtering, and MD validationPublisher siteScientific Reports, Computational Drug Discovery Methods
15 Jun 2026Open access
Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityPublisher siteFrontiers in Pharmacology, Cancer therapeutics and mechanisms
15 May 2026
Design and Synthesis of Indole-Based Imidazo[1,2- <i>a</i> ]pyridine Derivatives as Antiseizure Candidates: Evaluation in Chemically Induced Seizure Models and <i>In Vitro</i> Antioxidant AssaysPublisher siteACS Chemical Neuroscience, Synthesis and Reactivity of Heterocycles
26 Mar 2026
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluationsPublisher siteBioorganic Chemistry, Cancer-related Molecular Pathways
4 Mar 2026Open access
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityPublisher siteFrontiers in Pharmacology, Cancer therapeutics and mechanisms
1 Mar 2026Open access
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major GrowthPublisher siteDrug Design Development and Therapy, Research on Leishmaniasis Studies
18 Dec 2025Open access
Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitizationPublisher siteRSC Medicinal Chemistry
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Zainab?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you